Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-16

Clinical Trial Update: Sirolimus Use in Angioplasty for Vascular Access Extension [Phase 2]

View source ↗

Summary

Phase 2 trial update on sirolimus use in angioplasty for vascular access extension in end-stage renal disease with venous stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: End Stage Renal Disease, Venous Stenosis | Phase 2 | Status: COMPLETED